𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Early landmark analysis of imatinib treatment in CML chronic phase: Less than 10% BCR-ABL by FISH at 3 months associated with improved long-term clinical outcome

✍ Scribed by Lotta Ohm; Ingrid Arvidsson; Gisela Barbany; Robert Hast; Leif Stenke


Book ID
111994803
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
914 KB
Volume
87
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.